Diabetology & Metabolic Syndrome

Journal Title
Diabetology & Metabolic Syndrome

DIABETOL METAB SYNDR

ISSN / eISSN
1758-5996 / 1758-5996
Aims and Scope
Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome.

By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.
Subject Area

ENDOCRINOLOGY & METABOLISM

CiteScore
6.70 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Internal Medicine Q1 #31/140
Medicine - Endocrinology, Diabetes and Metabolism Q2 #64/232
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
ENDOCRINOLOGY & METABOLISM - SCIE Q2
H-index
38
Country/Area of Publication
BRAZIL
Publisher
BioMed Central
Year Publication Started
2009
Annual Article Volume
192
Open Access
YES
Contact
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
July 3, 2023: Submission status date, publication and permissions completed
June 30, 2023: Submission content being published and copyrighted
June 15, 2023: Submission accepted
June 6, 2023: Submission under peer review
June 6, 2023: Submission file passed technical check
June 5, 2023: Revision received
March 11, 2023: Submission under peer review
March 11, 2023: Submission file passed technical check
March 9, 2023: Submission file undergoing technical check
March 9, 2023: Submission received
2023-07-28

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now